Co-Diagnostics, Inc. (CODX) SEC Filings — 2025
17 SEC filings for Co-Diagnostics, Inc. (CODX) in 2025.
Filings
- Co-Diagnostics, Inc. 8-K Filing — 8-K · Dec 30, 2025
- Co-Diagnostics Files 8-K on Security Holder Vote Matters — 8-K · Dec 5, 2025
- CODX Revenue Plummets 90% Amid Going Concern Doubts — 10-Q · Nov 13, 2025
- CODX Seeks Reverse Split to Avoid Nasdaq Delisting — DEF 14A · Nov 10, 2025
- Co-Diagnostics, Inc. Files 8-K for Material Agreement — 8-K · Oct 29, 2025
- Co-Diagnostics Enters and Terminates Material Agreements — 8-K · Oct 20, 2025
- Co-Diagnostics, Inc. Files 8-K on Sept 30, 2025 — 8-K · Sep 30, 2025
- Co-Diagnostics Enters Material Definitive Agreement — 8-K · Sep 18, 2025
- CODX Revenue Plummets Amid Grant Loss, Going Concern Doubts Emerge — 10-Q · Aug 14, 2025
- Co-Diagnostics Appoints New Chief Medical Officer — 8-K · Jul 11, 2025
- Co-Diagnostics, Inc. Files 8-K on Shareholder Votes — 8-K · May 29, 2025
- Co-Diagnostics Q1 Revenue Declines — 10-Q · May 8, 2025
- Co-Diagnostics Enters Material Definitive Agreement — 8-K · Apr 28, 2025
- Co-Diagnostics Executive Compensation Revealed — DEF 14A · Apr 14, 2025
- Co-Diagnostics Files 2024 10-K — 10-K · Mar 27, 2025
- Co-Diagnostics Files 8-K: Corporate Details Updated — 8-K · Feb 21, 2025
- Co-Diagnostics Faces Delisting Notice — 8-K · Jan 10, 2025